Blog Posts by Date: Mar 2023
Avoiding LIS Disruptions: Applying Lessons Learned from Southwest Airlines
This blog expands on the impact related to a recent blog, "What Can Medical Providers Learn from the Southwest Airlines Fiasco." If you missed that blog, we encourage you to read it. In healthcare, especially laboratory testing, a significant percentage of medical decisions are based on test results. Laboratory test results influence approximately...
Measuring Real Client Profitability for Diagnostic Providers with Large National Sales Teams
Finance and sales executives for diagnostics companies with large national sales teams are becoming sophisticated in measuring sales productivity in terms of number of calls, revenue per client, revenue per rep, and even revenue per call. To better serve clients and patients, providers can leverage analytics covering the full transaction cycle—...
Optimizing Billing and Cash Collection—Valuable Lessons Specialty Providers Can Learn from Clinical Laboratories
In our work at XiFin, we support a wide variety of medical providers, many of whom share similar challenges. While our founders and initial clients come from the laboratory space, we see an expanding need for flexible revenue cycle technology and services in other specialty and ancillary spaces. Specialty providers like radiologists,...
Outsourcing Your Billing Processes: When does it make sense for outpatient diagnostic services?
From IT and EHR support to back-office functions, hospitals are increasingly turning to business process outsourcing (BPO) to relieve staffing and financial pressures. Within the hospital ecosystem – where technology and processes are typically optimized for high-acuity clinical encounters – outpatient and ancillary services departments can find...
Automation Strategies for Molecular Diagnostic Market-Share Expansion
This blog post is the third in our series covering the keys to success for market-share expansion in molecular diagnostics based on our recently published whitepaper, “The Executive’s Guide to Molecular Diagnostic Market-Share Expansion”. If you missed either of the first two posts in this series, you can find the first post, “Molecular Diagnostic...